Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Verrica Pharmaceuticals (1NE0) vs. Competitors

1 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
DE:1NE0Verrica PharmaceuticalsEUR 2.84EUR 44.71M-1.25-18.86%Strong BuyUnlock the DE:1NE0 analyst price target with TipRanks PremiumDE:1NE0Unlock the DE:1NE0 top-analyst price target with TipRanks Premium
ELUTElutia$0.83$36.76M0.6519.25%Moderate BuyUnlock the ELUT analyst price target with TipRanks PremiumDE:1NE0 vs ELUTUnlock the ELUT top-analyst price target with TipRanks Premium
EVAXEvaxion Biotech$2.54$23.19M-0.41-51.71%Strong BuyUnlock the EVAX analyst price target with TipRanks PremiumDE:1NE0 vs EVAXUnlock the EVAX top-analyst price target with TipRanks Premium
LIMNLiminatus Pharma$2.68$3.60M-0.11-95.17%―Unlock the LIMN analyst price target with TipRanks PremiumDE:1NE0 vs LIMNUnlock the LIMN top-analyst price target with TipRanks Premium

Performance Comparison

-100%-50%0%50%100%150%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
DE:1NE0Verrica Pharmaceuticals2.84-0.94-24.87%
ELUTElutia0.830.1725.95%
EVAXEvaxion Biotech2.54-2.34-47.95%
LIMNLiminatus Pharma2.68-53.32-95.21%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts